My community has been justifiably outraged with footage of the past treatment of sheep within the live export trade. I have met with my constituents and heard their concerns. If the export industry is to continue, unacceptable practices need to change so that such images will never be seen again.

What the government's done is place new conditions on sheep exporters, including: reducing stock densities; having independent observers on each boat sending back photo and written evidence daily; having independent auditing of pen ventilation readings; ensuring vessels have automatic watering installed for each sheep deck; and reducing the notifiable mortality level for sheep exported by sea from two to one per cent.

In 2017, there were 1.7 million live sheep exported by sea, and 99.29 per cent were delivered in good health. But what has been unacceptable is the footage that my people have seen.

I'm the member for McMillan. I represent a rural-regional seat. The concerns of my constituents are genuine, and I want to say to each one of the many people that have come to see me, the people that have emailed me and people that have written me cards and letters: if this trade is not cleaned up, if they do not perform what the government has called for, this trade will end. I have heard you and I'm responding to what you've said.

 

The Morrison Government will subsidise a life-changing cystic fibrosis medicine which significantly extends the lives of patients while saving families up to a quarter of a million dollars a year.

Orkambi® will be available on the Pharmaceutical Benefits Scheme (PBS) from 1 October 2018 for all patients over the age of 6 years who have the most the most common form of cystic fibrosis - two copies of the f508del mutation in the CFTR gene.

Member for McMillan, Russell Broadbent said that this will provide over 1,200 Australian patients, and their families, with a longer and better life.

“The Morrison Government’s plan to keep our economy strong means we can guarantee the essential services Australians rely on, including subsidising such life-saving medicines,” Mr Broadbent said.

From the start of September all eligible patients can access the medicine immediately with Vertex agreeing to provide compassionate free access until the medicine is listed on the on the PBS on 1 October.

“Patients would otherwise pay up to $250,000 a year for Orkambi but with the Morrison Government’s investment they will now only pay a maximum of $39.50 per script, with concessional patients paying just $6.40.

“This is a landmark listing and we know how much it means to the entire cystic fibrosis community.

“This medicine has been out of reach for many Australian families until now. It is truly life-changing for so many families and it will deliver joy, happiness and the hope of a better life.

Cystic fibrosis is a progressive, genetic disease that causes persistent lung infections and limits the ability to breathe over time. A defective gene causes a thick, sticky build- up of mucus in the lungs, pancreas, and other organs. Orkambi has been shown to slow the rate of decline in lung function and reduce the number of infections in people with cystic fibrosis.

“We moved as quickly as possible to fund Orkambi following a positive recommendation from the independent Pharmaceutical Benefits Advisory Committee (PBAC).

The PBAC is independent of Government by law and in practice. By law the Federal Government cannot list a new medicine without a positive recommendation from PBAC.

Since coming into Government, the Coalition has helped improve the health of Australians by subsidising more than $9 billion worth of new medicines.

“In the recent Budget we announced our commitment to invest $2.4 billion in new medicines to build on our commitment to guarantee the essential services that all Australians rely on.

“Our commitment to the PBS is rock solid. Together with Medicare, it is a foundation of our world-class health care system,” Mr Broadbent said.

Russell Broadbent MP
Sign up here to receive the latest news from my inbox.
crossmenuarrow-up-circle